DSM Panel Members Still Getting Pharma Funds
Despite promises to cut back on Pharma funds, 56% of DSM V panel members have reported industry ties— Zero improvement over the percent of DSM-IV members.
Despite promises to cut back on Pharma funds, 56% of DSM V panel members have reported industry ties— Zero improvement over the percent of DSM-IV members.
As psychiatrists from around the world flood the area this weekend to take part in the Annual Meeting of the American Psychiatric Association (APA), psychiatric watchdog Citizens Commission on Human Rights (CCHR) is demanding that the APA sever all ties to pharmaceutical company interests and that psychiatrists stop killing children with harmful drugs.
One of the most controversial proposed disorders for the upcoming revision of psychiatry’s billing bible of mental disorders, (the DSM-5) is Psychosis Risk Syndrome (PRS) a “mental disorder” that, if voted into DSM, would confirm the allegations that psychiatry is manufacturing a Brave New World for itself—heavily backed by Big Pharma—of drugging children before they develop a “mental illness.”
The new fourth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association may define several new psychiatric disorders. Some of these do not sound like varieties of mental illness at all, but rather opinions and attitudes. What would “oppositional defiant disorder,” for example, represent?
Proposed changes to the U.S. Diagnostic and Statistical Manual (DSM) could include reclassifying childhood temper tantrums, teenage angst, and binge eating as psychiatric disorders. If accepted, the proposals could equal billions of dollars in new revenue for pharmaceutical companies.